Applied DNA Sciences, Inc.
APDN · NASDAQ
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Revenue | $3,431 | $13,367 | $18,169 | $9,028 |
| % Growth | -74.3% | -26.4% | 101.3% | – |
| Cost of Goods Sold | $2,415 | $7,834 | $13,115 | $4,099 |
| Gross Profit | $1,017 | $5,533 | $5,054 | $4,928 |
| % Margin | 29.6% | 41.4% | 27.8% | 54.6% |
| R&D Expenses | $3,594 | $3,735 | $3,926 | $3,765 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $11,448 | $12,752 | $15,097 | $12,611 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $844 |
| Operating Expenses | $15,042 | $16,487 | $19,023 | $17,220 |
| Operating Income | -$14,025 | -$10,953 | -$13,970 | -$12,292 |
| % Margin | -408.7% | -81.9% | -76.9% | -136.2% |
| Other Income/Exp. Net | $6,936 | $930 | $5,700 | -$1,752 |
| Pre-Tax Income | -$7,088 | -$10,023 | -$8,270 | -$14,278 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$6,993 | -$9,947 | -$8,378 | -$16,029 |
| % Margin | -203.8% | -74.4% | -46.1% | -177.6% |
| EPS | -1.82 | -15.21 | -18.68 | -46.35 |
| % Growth | 88% | 18.6% | 59.7% | – |
| EPS Diluted | -1.82 | -15.21 | -18.68 | -46.35 |
| Weighted Avg Shares Out | 3,966 | 654 | 448 | 346 |
| Weighted Avg Shares Out Dil | 3,966 | 654 | 448 | 346 |
| Supplemental Information | – | – | – | – |
| Interest Income | $176 | $75 | $7 | $14 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $696 | $1,362 | $1,290 | $844 |
| EBITDA | -$13,328 | -$9,591 | -$12,679 | -$11,682 |
| % Margin | -388.4% | -71.7% | -69.8% | -129.4% |